Abivax S.A.

NASDAQ: ABVX · Real-Time Price · USD
68.11
-0.85 (-1.23%)
At close: Aug 20, 2025, 10:00 AM

Abivax S.A. Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
10.79M 4.62M 4.58M 37K
Cost of Revenue
n/a n/a 110K 156K
Gross Profit
10.79M 4.57M 4.47M -119K
Operating Income
-172.98M -127.38M -64.84M -41.4M
Interest Income
n/a 2.77M n/a 84K
Pretax Income
-176.24M -152.23M -74.32M -42.45M
Net Income
-176.24M -147.74M -60.74M -42.45M
Selling & General & Admin
38.9M 28.82M 7.49M 5.58M
Research & Development
146.53M 103.18M 48.73M 47.78M
Other Expenses
-1.66M -47K n/a -11.96M
Operating Expenses
183.78M 127.38M 56.54M 42.6M
Interest Expense
n/a 13.83M 6.94M 3.56M
Selling & Marketing Expenses
5.95M 709K n/a n/a
Cost & Expenses
183.78M 131.95M 56.65M 42.6M
Income Tax Expense
n/a -4.49M -4.48M n/a
Shares Outstanding (Basic)
63.05M 43.07M 19.09M 15.46M
Shares Outstanding (Diluted)
63.05M 43.07M 19.09M 15.46M
EPS (Basic)
-2.8 -3.43 -3.18 -2.75
EPS (Diluted)
-2.8 -3.43 -3.18 -2.75
EBITDA
-171.88M -133.21M -53.31M -38.59M
EBIT
-172.98M -133.91M -53.8M -38.89M
Depreciation & Amortization
1.1M 707K 485K 156K